Stemtech annual stock-based compensation
2020
2021
2022
2023
2024
2025
Stemtech Stock-Based Compensation Growth & History (STEK)
Stemtech's stock-based compensation was $439,054 for fiscal 2025.
View full Stemtech company overviewStemtech annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $439,054 | −$1,202 | −0.27% |
| 2024 | 2024-12-31 | $440,256 | $1,202 | +0.27% |
| 2023 | 2023-12-31 | $439,054 | −$3.6M | −89.01% |
| 2022 | 2022-12-31 | $4.0M | $3.0M | +287.54% |
| 2021 | 2021-12-31 | $1.0M | $580,673 | +128.90% |
| 2020 · Dec 31 | 2020-12-31 | $450,500 | — | — |
Stemtech quarterly stock-based compensation
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $109,463 | $1 | +0.00% |
| Q1 2026 | 2026-03-31 | $108,260 | $0 | 0.00% |
| Q4 2025 | 2025-12-31 | $110,666 | −$98,394 | −47.06% |
| Q3 2025 | 2025-09-30 | $110,666 | $110,666 | — |
| Q2 2025 | 2025-06-30 | $109,462 | −$12,271 | −10.08% |
| Q1 2025 | 2025-03-31 | $108,260 | −$1,203 | −1.10% |
| Q4 2024 | 2024-12-31 | $209,060 | $98,394 | +88.91% |
| Q3 2024 | 2024-09-30 | $0 | −$110,665 | — |
| Q2 2024 | 2024-06-30 | $121,733 | $12,270 | +11.21% |
| Q1 2024 | 2024-03-31 | $109,463 | $1,203 | +1.11% |
| Q4 2023 | 2023-12-31 | $110,666 | −$3.6M | −96.98% |
| Q3 2023 | 2023-09-30 | $110,665 | $0 | 0.00% |
| Q2 2023 | 2023-06-30 | $109,463 | $0 | 0.00% |
| Q1 2023 | 2023-03-31 | $108,260 | $0 | 0.00% |
| Q4 2022 | 2022-12-31 | $3.7M | — | — |
| Q3 2022 | 2022-09-30 | $110,665 | −$148,335 | −57.27% |
| Q2 2022 | 2022-06-30 | $109,463 | −$195,864 | −64.15% |
| Q1 2022 | 2022-03-31 | $108,260 | $46,583 | +75.53% |
| Q3 2021 | 2021-09-30 | $259,000 | — | — |
| Q2 2021 · Jun 30 | 2021-06-30 | $305,327 | — | — |
| Q1 2021 · Mar 31 | 2021-03-31 | $61,677 | — | — |
Stemtech stock-based compensation trends
Over the last five fiscal years, Stemtech's stock-based compensation decreased from $450,500 to $439,054, a change of −$11,446. The latest reported quarter, Q2 2026, shows $109,463.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Stemtech source filings ↗